We are pleased to invite you to the Demo Day of our KQ Labs Cohort #2, an intensive accelerator programme offered to high growth potential startup teams in the area of data-driven biomedical science.

Ten selected startups have completed a 16-week intensive programme delivered by the Francis Crick Institute. They have been provided with a £40K convertible loan, and have had access to a network of global experts in all aspects of entrepreneurship, health sector knowledge and data science. KQ Labs Cohort #2 is funded by The Wellcome Trust.

Agenda

The startups will each present, followed by networking drinks; an opportunity for startups, investors, scientists and industry leaders to gather.

1430 Arrivals and refreshments

1500 Welcome, Introductions and Startup Pitches (1-5)

1620 Break

1640 Startup pitches (6-10)

1730 Networking drinks

Looking forward to seeing you at our Demo Day for what promises to be a valuable and insightful afternoon!

Meet the current cohort:

Base Immune offer data-driven solutions to vaccine design. Their mission is to monitor and integrate big-data on genomics, proteomics, as well as geographical and clinical data into the antigen discovery and vaccine development pipeline.

Bold Health is a digital therapeutic platform leveraging behavioural medicine and data science to create personalised care programs for the self-management of chronic digestive conditions, starting with irritable bowel syndrome.

Imera uses machine learning to support radiologists to identify fractures in patients more effectively.

Jiva is a machine learning platform that puts model integration at the centre of its data science workflow and is currently engaged in identification and diagnosis of prostate cancer from MRI scans.

My Personal Therapeutics identifies highly precise combinations of FDA-approved drugs to target an individual patient’s tumour. Our personalised cancer therapeutics technology, the Personal Discovery Process, was developed Mt Sinai Medical Center in New York.

Pexxi is a precision medicine platform, matching women with the optimal oral contraceptives based on their medical history, hormone levels and genetic profile.

Oppilotech have developed a high-resolution platform based on systems biology and machine learning to model biological processes in cells. We utilise the platform to identify first-in-class drug targets and then develop drugs that modulate the identified targets.

Pharmenable explores new areas of the chemical space that no one else is currently searching to enable the development of vital new medicines.

Sano Genetics is a platform for personalised medicine that connects people with relevant research studies and clinical trials based on their genetic and health data.

Zetta Genomics provides the big data foundation for generation genome. Our distributed storage and analysis technology provides the quality and convenience needed to move genomics from research to medicine at scale.

KQ Labs Accelerator -Demo Day Event